Korean J Gastroenterol.  2019 Aug;74(2):95-100. 10.4166/kjg.2019.74.2.95.

Emotional Support and Palliative Care for Distressed Patients Suffering from Pancreatic Cancer

• Park HY

• KMID: 2455772
• DOI: http://doi.org/10.4166/kjg.2019.74.2.95

Abstract

Pancreatic cancer is associated with a poor prognosis and high mortality. Thus, distress that includes depression and anxiety is a relatively common comorbidity for patients suffering from pancreatic cancer. However, these psychological symptoms are likely to be under-detected and undertreated. Regarding high levels of unmet needs of psychological support for patients with pancreatic cancer, early screening for distress and adequate interventions should be considered in palliative care settings. Suicide, a common but preventable cause of mortality for patients with pancreatic cancer, also deserves the further attention of care providers. Still, there have been limited studies that have documented psychological support for this population. Future research is needed to elucidate appropriate psychological care and models of services for patients suffering from pancreatic cancer.

Keyword

Pancreatic neoplasms; Palliative care; Emotions; Anxiety; Depression

MeSH Terms

Anxiety
Comorbidity
Depression
Humans
Mass Screening
Mortality
Palliative Care*
Pancreatic Neoplasms*
Prognosis
Suicide

Reference

1. Clark KL, Loscalzo M, Trask PC, Zabora J, Philip EJ. Psychological distress in patients with pancreatic cancer--an understudied group. Psychooncology. 2010; 19:1313–1320.

2. Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S. The prevalence of psychological distress by cancer site. Psychooncology. 2001; 10:19–28.

3. Chida Y, Hamer M, Wardle J, Steptoe A. Do stress-related psychosocial factors contribute to cancer incidence and survival? Nat Clin Pract Oncol. 2008; 5:466–475.

4. Beesley VL, Janda M, Goldstein D, et al. A tsunami of unmet needs: pancreatic and ampullary cancer patients' supportive care needs and use of community and allied health services. Psychooncology. 2016; 25:150–157.

5. Engebretson A, Matrisian L, Thompson C. Pancreatic cancer: patient and caregiver perceptions on diagnosis, psychological impact, and importance of support. Pancreatology. 2015; 15:701–707.

6. Carlson LE, Groff SL, Maciejewski O, Bultz BD. Screening for distress in lung and breast cancer outpatients: a randomized controlled trial. J Clin Oncol. 2010; 28:4884–4891.

7. NCCN guidelines^® & clinical resources. [Internet]. Plymouth Meeting (PA): National Comprehensive Cancer Network;c2005. cited 2019 Jul 5. Available from: https://www.nccn.org/professionals/physician_gls/default.aspx#supportive.

8. Shim EJ, Shin YW, Jeon HJ, Hahm BJ. Distress and its correlates in Korean cancer patients: pilot use of the distress thermometer and the problem list. Psychooncology. 2008; 17:548–555.

9. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67:361–370.

10. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961; 4:561–571.

11. KimJH. Development of recommendations for distress management toward improvement of quality of life in cancer patients. [Internet]. Seoul: Ministry for Health, Welfare and Family Affairs;2009. 05. cited 2019 Jul 5]. Available from: http://www.ndsl.kr/ndsl/commons/util/ndslOriginalView.do?dbt=TRKO&cn=TRKO200900074313&rn=&url=&pageCode=PG18.

12. Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr. 2004; (32):57–71.

13. Walker J, Hansen CH, Martin P, et al. Prevalence, associations, and adequacy of treatment of major depression in patients with cancer: a cross-sectional analysis of routinely collected clinical data. Lancet Psychiatry. 2014; 1:343–350.

14. Jia L, Jiang SM, Shang YY, et al. Investigation of the incidence of pancreatic cancer-related depression and its relationship with the quality of life of patients. Digestion. 2010; 82:4–9.

15. Barnes AF, Yeo TP, Leiby B, Kay A, Winter JM. Pancreatic cancer-associated depression: a case report and review of the literature. Pancreas. 2018; 47:1065–1077.

16. Burrell SA, Yeo TP, Smeltzer SC, et al. Symptom clusters in patients with pancreatic cancer undergoing surgical resection: part II. Oncol Nurs Forum. 2018; 45:E53–E66.

17. Fisch MJ, Loehrer PJ, Kristeller J, et al. Fluoxetine versus placebo in advanced cancer outpatients: a double-blinded trial of the Hoosier Oncology Group. J Clin Oncol. 2003; 21:1937–1943.

18. Sharpe M, Strong V, Allen K, et al. Major depression in outpatients attending a regional cancer centre: screening and unmet treatment needs. Br J Cancer. 2004; 90:314–320.

19. Boyd CA, Benarroch-Gampel J, Sheffield KM, Han Y, Kuo YF, Riall TS. The effect of depression on stage at diagnosis, treatment, and survival in pancreatic adenocarcinoma. Surgery. 2012; 152:403–413.

20. Velanovich V. The association of quality-of-life measures with malignancy and survival in patients with pancreatic pathology. Pancreas. 2011; 40:1063–1069.

21. Sharpe M, Walker J, Holm Hansen C, et al. Integrated collaborative care for comorbid major depression in patients with cancer (SMaRT Oncology-2): a multicentre randomised controlled effectiveness trial. Lancet. 2014; 384:1099–1108.

22. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5®). 5th ed. Washington, DC: American Psychiatric Association;2013.

23. Li M, Fitzgerald P, Rodin G. Evidence-based treatment of depression in patients with cancer. J Clin Oncol. 2012; 30:1187–1196.

24. Hart SL, Hoyt MA, Diefenbach M, et al. Meta-analysis of efficacy of interventions for elevated depressive symptoms in adults diagnosed with cancer. J Natl Cancer Inst. 2012; 104:990–1004.

25. Breitbart W, Rosenfeld B, Gibson C, et al. Meaning-centered group psychotherapy for patients with advanced cancer: a pilot randomized controlled trial. Psychooncology. 2010; 19:21–28.

26. Chochinov HM, Kristjanson LJ, Breitbart W, et al. Effect of dignity therapy on distress and end-of-life experience in terminally ill patients: a randomised controlled trial. Lancet Oncol. 2011; 12:753–762.

27. Robson A, Scrutton F, Wilkinson L, MacLeod F. The risk of suicide in cancer patients: a review of the literature. Psychooncology. 2010; 19:1250–1258.

28. Anguiano L, Mayer DK, Piven ML, Rosenstein D. A literature review of suicide in cancer patients. Cancer Nurs. 2012; 35:E14–E26.

29. Turaga KK, Malafa MP, Jacobsen PB, Schell MJ, Sarr MG. Suicide in patients with pancreatic cancer. Cancer. 2011; 117:642–647.

30. Breitbart W, Rosenfeld B, Pessin H, et al. Depression, hopelessness, and desire for hastened death in terminally ill patients with cancer. JAMA. 2000; 284:2907–2911.

31. Chochinov HM, Hack T, Hassard T, Kristjanson LJ, McClement S, Harlos M. Understanding the will to live in patients nearing death. Psychosomatics. 2005; 46:7–10.

32. Remes O, Brayne C, Van Der Linde R, Lafortune L. A systematic review of reviews on the prevalence of anxiety disorders in adult populations. Brain Behav. 2016; 6:e00497.

33. Roth AJ, Massie MJ. Anxiety in palliative care. In : Chochinov HM, Breitbart WS, editors. Handbook of psychiatry in palliative medicine. 2nd ed. New York: Oxford University Press, Inc.;2009. p. 69–80.

34. Miovic M, Block S. Psychiatric disorders in advanced cancer. Cancer. 2007; 110:1665–1676.

35. Traeger L, Greer JA, Fernandez-Robles C, Temel JS, Pirl WF. Evidence-based treatment of anxiety in patients with cancer. J Clin Oncol. 2012; 30:1197–1205.

36. Elia G, Thomas J. The symptomatic relief of dyspnea. Curr Oncol Rep. 2008; 10:319–325.

37. Classen C, Butler LD, Koopman C, et al. Supportive-expressive group therapy and distress in patients with metastatic breast cancer: a randomized clinical intervention trial. Arch Gen Psychiatry. 2001; 58:494–501.

38. Jaiswal R, Alici Y, Breitbart W. A comprehensive review of palliative care in patients with cancer. Int Rev Psychiatry. 2014; 26:87–101.

39. Chochinov HM, Breitbart WS. Handbook of psychiatry in palliative medicine. 2nd ed. New York: Oxford University Press, Inc.;2009.